AstraZeneca

India will begin immunising the public from next month, starting with those over 50 or with medical conditions

AstraZeneca India has received marketing authorisation for their anti-diabetic drug dapagliflozin, in India for the treatment of…

In a recent statement, AstraZeneca said it was considering how it could assess combinations of different vaccines, and would soon…

Half dose, followed by a full dose at least one month apart shows 90 per cent efficacy, while two full doses at same interval…

It was possible that there would be vaccines available by the end of the year

This proves that science is moving forward very quickly, which is a good sign

J&J is said it plans to start the first human trials of its COVID-19 vaccine on July 22 and could kick off late-stage studies…

The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of…

The approval was based on results from a late-stage trial in which Lynparza nearly doubled the lifespan of patients AstraZeneca…

8,000 volunteers had been enrolled for the Phase III of its trial into the vaccine, AZD1222, which was licensed to AstraZeneca…